Analisis Efektivitas Biaya Penggunaan Insulin Lantus dan Apidra di RSUD Dr. R. Soedjono Selong

Authors

  • Erma Ewisa Oktresia Universitas Hamzanwadi
  • Fitriwati Sovia Universitas Hamzanwadi
  • Leny Ramadhan Universitas Hamzanwadi
  • Lalu Khilal Ramadani Universitas Hamzanwadi

DOI:

https://doi.org/10.29408/sinteza.v4i2.26475

Keywords:

ACER, Diabetes Mellitus, Insulin, Length of Stay

Abstract

Indonesia is one of the countries with the highest number of type II diabetes mellitus patients in the world, reaching 10.7 million people. Diabetes mellitus requires long-term treatment to control patients' blood glucose levels. The types of therapy used vary, leading to differences in costs and treatment outcomes. The use of insulin is a significant issue in diabetes mellitus therapy, especially at RSUD Dr. R. Soedjono, concerning its cost-effectiveness and therapeutic efficacy. This study aims to analyze the cost-effectiveness of using Lantus and Apidra insulin therapies.This research is an observational analytic study with a cross-sectional design, and data collection was conducted retrospectively at RSUD Dr. R. Soedjono Selong. The sample selection was based on predetermined inclusion and exclusion criteria. Observations were made on the Length of Stay (LOS) and Direct Medical Cost (DMC) for each sample. Based on LOS and DMC data, the Average Cost-Effectiveness Ratio (ACER) was calculated. The results showed that the average LOS for Lantus insulin use was 4 days, while for Apidra insulin use, it was 5 days. The average DMC for Lantus insulin was Rp.2,395,734, while for Apidra insulin, it reached Rp. 2,590,218. Based on LOS and DMC data, the ACER value for Lantus insulin was Rp 598,934/day, while for Apidra insulin, it was Rp 518,043/day. The use of Apidra insulin is more cost-effective because it has a lower ACER value.

References

Amirulah, F., Yulianti, & Yanti, S. I. (2024). Gambaran Tingkat Pengetahuan dan Perilaku Responden pada Penggunaan Sunscreen di Klinik Kecantikan Wilayah Bekasi. Sinteza, 4(1), 1–7. https://doi.org/10.29408/sinteza.v4i1.7926

Andayani, T. M. (2013a). Farmakoekonomi : Prinsip dan Metodologi. Bursa Ilmu.

Andayani, T. M. (2013b). Farmakoekonomi : Prinsip dan Metodologi. Bursa Ilmu.

Ariawan, M. W., Yovita, Lestari, E., & Elvanur, S. (2017). Analisis Efektivitas Biaya Pengobatan Pasien Diabetes Tipe 2 Dengan Terapi Glibenklamid Dan Metformin Pasien Bpjs Rawat Inap Di Rsud Sukoharjo. Journal of Pharmaceutical Science, 4(1), 1–8.

Baroroh, F. B., & Fauzi, L. A. (2017). Analisis biaya terapi stroke pada pasien rawat inap di rumah sakit PKU muhammadiyah bantul yogyakarta. Jurnal Ilmiah Ibnu Sina, 2(1), 93–101.

Depkes RI. (2019). Laporan Riskesdas 2019. Kemenkes RI.

Eledrisi, M. S., & Danjuma, M. I.-M. (2024). Comparison of Insulin Analogs and Human Insulins: A Narrative Review. Journal of Diabetes and Endocrine Practice, 07(01), 5–14. https://doi.org/10.1055/s-0043-1771027

Fitri, E. (2015). Analisis Biaya Penyakit Diabetes Mellitus di Rsup Dr. Sardjito Yogyakarta. Universitas Gadjah Mada.

Friel, K. M., McCauley, C., O’Kane, M., McCann, M., Delaney, G., & Coates, V. (2022). Can Clinical Outcomes Be Improved, and Inpatient Length of Stay Reduced for Adults With Diabetes? A Systematic Review. Frontiers in Clinical Diabetes and Healthcare, 3. https://doi.org/10.3389/fcdhc.2022.883283

Hadning, I., Ikawati, Z., & Andayani, T. M. (2015). Stroke Treatment Cost Analysis for Consideration on Health Cost Determination Using INA- CBGs at Jogja Hospital. International Journal of Public Health Science (IJPHS), 4(4), 288–293.

IDF. (2017). Internasional Diabetes Federation.

Imelda, S. (2019). Faktor-Faktor Yang Mempengaruhi Terjadinya diabetes Melitus di Puskesmas Harapan Raya Tahun 2018. In Scientia Journal (Vol. 8, Issue 1).

Kemenkes RI. (2020). Infodatin 2020 Diabetes Melitus Pusat dan Informasi Kementerian RI.

Lestari, Zulkarnain, & Sijid, S. A. (2021). Diabetes Melitus: Review Etiologi, Patofisiologi, Gejala, Penyebab, Cara Pemeriksaan, Cara Pengobatan dan Cara Pencegahan. http://journal.uin-alauddin.ac.id/index.php/psb

Lih, A., Hibbert, E., Wong, T., Girgis, C. M., Garg, N., & Carter, J. N. (2010). The role of insulin glulisine to improve glycemic control in children with diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity, 3, 403–412. https://doi.org/10.2147/DMSOTT.S5116

Lubis, I. K., & Susilawati. (2017). Analisis Length Of Stay (Los) Berdasarkan Faktor Prediktor Pada Pasien DM Tipe II di RS PKU Muhammadiyah Yogyakarta. Jurnal Kesehatan Vokasional, 2(2), 161–166.

Marhenta, Y. B., Siwi, M. A. A., & Aprilianur, D. (2018). Analisis Efektifitas Biaya Terapi Kombinasi Antihipertensi Pasien Hipertensi dengan Penyerta Diabetes Mellitus Tipe-2 Rsu Aminah Blitar. Jurnal Wiyata: Penelitian Sains Dan Kesehatan, 5(1), 44–51.

Nasution, F., Andilala, A., & Siregar, A. A. (2021). Faktor Risiko Kejadian Diabetes Mellitus. Jurnal Ilmu Kesehatan, 9(2), 94. https://doi.org/10.32831/jik.v9i2.304

Perkeni. (2021). Pengelolaan dan Pencegahan Diabetes Mellitus Tipe II di Indonesia.

Priharsi, A. (2015). Analisis Efektivitas Biaya Antidiabetik Oral pada Penderita Diabetes Melitus Tipe 2 Rawat Jalan Peserta Bpjs di Rumah Sakit Umum Daerah Dr. Moewardi Tahun 2014. Universitas Muhammadiyah Surakarta.

Rismayanthi, C. (2010). Terapi Insulin Sebagai Alternatif Pengobatan Bagi Penderita Diabetes. Medikora, VI, 29–36.

Rismayanti, M. (2019). Gambaran Pelaksanaan Program Pencegahan dan Pengendalian Infeksi Di Rumah Sakit Umum X Kota Y. In Jurnal Kesehatan Andalas (Vol. 8, Issue 1). http://jurnal.fk.unand.ac.id

Salim, M. F., Lubis, I. K., & Sugeng, S. (2019). Perbedaan Length of Stay (LOS) Pasien Diabetes Mellitus Berdasarkan Komplikasi Di RSUP Dr. Sardjito Yogyakarta. Jurnal Manajemen Informasi Kesehatan Indonesia, 7(1), 17. https://doi.org/10.33560/jmiki.v7i1.216

Sugumar, V., Ang, K. P., Alshanon, A. F., Sethi, G., Yong, P. V. C., Looi, C. Y., & Wong, W. F. (2022). A Comprehensive Review of the Evolution of Insulin Development and Its Delivery Method. Pharmaceutics, 14(7). https://doi.org/10.3390/pharmaceutics14071406

Wahyuni, N. K. E., Larasanthy, L. P. F., & Udayani, N. N. W. (2012). Fektivitas Biaya Penggunaan Terapi Kombinasi Insulin dan OHO pada Pasien Diabetes Tipe 2 Rawat.

WHO. (2016). Diabetes Country Profile Indonesia.

Yuliana, T. P. (2021). Pemberian Ramuan Pengobat Tradisional Kaliputih Terhadap Kadar Gula Darah Tikus Diabetes. Sinteza, 1(1), 7–15.

Yulianti, S. R., Mukaddas, A., & Faustine, I. (2014). Profil Pengobatan Pasien Diabetes Mellitus Tipe 2 di Instalasi Rawat Inap RSUD Undata Palu Tahun 2012. Online Jurnal of Natural Science, 3(1), 40–46.

Downloads

Published

2024-08-04

How to Cite

Oktresia, E. E., Sovia, F., Ramadhan, L., & Ramadani, L. K. (2024). Analisis Efektivitas Biaya Penggunaan Insulin Lantus dan Apidra di RSUD Dr. R. Soedjono Selong. Sinteza, 4(2), 94–100. https://doi.org/10.29408/sinteza.v4i2.26475

Issue

Vol. 4 No. 2 (2024): August

Section

Articles

License

Copyright (c) 2024 Sinteza

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in Sinteza, agree to retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, web sites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.